The Clackmannanshire-based business this week announced a material transfer agreement to allow Mologic access to its facility in Littleport, Cambridgeshire, to manufacture its Elisa test.
The test has been part-funded by the UK Government and is designed to indicate whether people have had the Covid-19 virus, may have immunity to it and could therefore return to relatively normal life.
This is another example of the UK diagnostics industry working in collaboration to bring effective solutions in the fight against this global pandemic.”
The Elisa test has been independently validated by the Liverpool School of Tropical Medicine and St George’s, University of London, and the test has been given to Public Health England and NHS Scotland for formal validation.
Omega is also part of a consortium working on a lateral flow antibody test which could quickly show presence of Covid-19 antibodies, which will be made at Omega’s base in Alva.